969 results
P
KLOTHO∗VS heterozygosity
I/C
KL∗VS, heterozygosity
O
P
CD152 polymorphism
I/C
rs231775, rs3087243, rs5742909, AA vs. GG, AA vs. AG, GG vs. AA, GA vs. GG, AA vs. GG + GA, GG vs. AA + AG, A vs. G, GA vs. GG
O
decreased cervical cancer risk, elevated disease onset
P
patients with malocclusion
I/C
extraction vs. nonextraction in orthodontic treatment, extraction vs. nonextraction
O
soft-tissue profile
P
patients with age-related macular degeneration (AMD), controls
I/C
IL-8 gene polymorphisms, IL-8 level, allelic (T vs. C), dominant (TT + CT vs. CC), homozygous (TT vs. CC), heterozygous (CT vs. CC)
O
risk of age-related macular degeneration (AMD), elevated level of IL-8, wet AMD
P
patients with clinically significant prostate cancer (csCaP)
I/C
MRI-guided software fusion biopsy (FB) using transrectal (TR) vs transperineal (TP) approaches, TR vs TP approaches
O
detection rate of clinically significant prostate cancer (csCaP)
P
young and middle-aged
I/C
high-intensity interval training (HIIT), moderate-intensity continuous training (MICT), within-group (pre-intervention vs. post-intervention), between-group (HIIT vs. MICT)
O
body composition, cardiorespiratory fitness (CRF)
P
neonates, sepsis cases, healthy controls
I/C
VDR SNPs, FokI, TaqI, BsmI, BgII, ApaI, CT vs. CC+TT, TT vs CT+CC, CC vs. CT+TT, C vs. T
O
neonatal sepsis
P
pregnant women
I/C
iron and folic acid supplementation, primipara vs multipara, anaemia vs non-anaemia, knowledgeable vs limited knowledge of anaemia, knowledgeable vs limited knowledge of iron and folic acid supplementation
O
adherence to iron and folic acid supplementation
P
resistance exercise
I/C
attentional focus, external focus vs. internal focus vs. control
O
muscular endurance
P
patients with Parkinson's disease
I/C
physical therapy (PT), nonstandard PT vs standard PT, PT vs no intervention
O
Unified Parkinson's Disease Rating Scale (UPDRS) score, measures of gait and balance, quality of life, cognition